Skip to main content
Access Resources

MJFF Publications

6181 - 6190 of 7540 Results
Title
Year
  • Year
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • 2015
  • RESTRICTED
    Title: Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.03.017
    Citation Count: 128
  • RESTRICTED
    Title: Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson’s disease patients? A Systematic Review
    Journal Name: Neuropsychology Review
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11065-015-9307-8
    Citation Count: 18
  • RESTRICTED
    Title: Effect of augmenting cholinergic function on gait and balance
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-015-0523-x
    Citation Count: 25
  • RESTRICTED
    Title: Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa, publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2015.11.018
    Citation Count: 214
  • RESTRICTED
    Title: IsPARKINparkinsonism a cancer predisposition syndrome?
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000031
    Citation Count: 3
  • RESTRICTED
    Title: Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-015-0449-7
    Citation Count: 99
  • RESTRICTED
    Title: Olfaction inParkinsingle and compound heterozygotes in a cohort of young onset Parkinson's disease patients
    Journal Name: Acta Neurologica Scandinavica
    Publisher: Hindawi Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ane.12538
    Citation Count: 21
  • RESTRICTED
    Title: Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.cell.2015.11.025
    Citation Count: 369
  • RESTRICTED
    Title: Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?
    Journal Name: Clinical Neurology and Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.clineuro.2015.10.019
    Citation Count: 7
  • RESTRICTED
    Title: Current disease modifying approaches to treat Parkinson’s disease
    Journal Name: Cellular and Molecular Life Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00018-015-2101-1
    Best OA location URL:
    Citation Count: 87
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.